Abstract  Dynorphin, an endogenous ligand of kappa (κ) opioid receptors, has multiple roles in the brain, and plays a positive role in energy balance and food intake. However, the mechanism for this is unclear. With immunocytochemistry, we find that axonal dynorphin immunoreactivity in the arcuate nucleus is strong, and that a large number of dynorphin‐immunoreactive boutons terminate on or near anorexigenic proopiomelanocortin (POMC) cells. Here we provide evidence from whole‐cell patch‐clamp recording that dynorphin‐A (Dyn‐A) directly and dose‐dependently inhibits arcuate nucleus POMC neurons. Dyn‐A inhibition was eliminated by the κ opioid receptor antagonist nor‐BNI, but not by the μ receptor antagonist CTAP. The inhibitory effect was mimicked by the κ₂ receptor agonist GR89696, but not by the κ₁ receptor agonist U69593. No presynaptic effect of κ₂ agonists was found. These results suggest that Dyn‐A inhibits POMC neurons through activation of the κ₂ opioid receptor. In whole‐cell voltage clamp, Dyn‐A opened G‐protein‐coupled inwardly rectifying potassium (GIRK)‐like channels on POMC neurons. Dynorphin attenuated glutamate and GABA neurotransmission to POMC neurons. In contrast to the strong inhibition of POMC neurons by Dyn‐A, we found a weaker direct inhibitory effect of Dyn‐A on arcuate nucleus neuropeptide Y (NPY) neurons mediated by both κ₁ and κ₂ receptors. Taken together, these results indicate a direct inhibitory effect of Dyn‐A on POMC neurons through activation of the κ₂ opioid receptor and GIRK channels. A number of orexigenic hypothalamic neurons release dynorphin along with other neuropeptides. The inhibition of anorexigenic POMC neurons may be one mechanism underlying the orexigenic actions of dynorphin.